26 results on '"Lynch, Thomas J."'
Search Results
2. Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials
3. Clinically Meaningful Improvement in Symptoms and Quality of Life for Patients With Non–Small-Cell Lung Cancer Receiving Gefitinib in a Randomized Controlled Trial
4. XPD and XRCC1 Genetic Polymorphisms Are Prognostic Factors in Advanced Non–Small-Cell Lung Cancer Patients Treated With Platinum Chemotherapy
5. The Phase III Trial in the Era of Targeted Therapy: Unraveling the “Go or No Go” Decision
6. The Impact of a Physician Awareness Group and the First Year of Training on Hematology-Oncology Fellows
7. Aggressive Treatment for the Fit Elderly With Non–Small-Cell Lung Cancer? Yes!
8. Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
9. Unmet Challenges in the Use of Novel Agents in Locally Advanced Non–Small-Cell Lung Cancer
10. Longitudinal Perceptions of Prognosis and Goals of Therapy in Patients With Metastatic Non–Small-Cell Lung Cancer: Results of a Randomized Study of Early Palliative Care
11. Reply to I. Floriani et al
12. Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non–Small-Cell Lung Cancer
13. Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non–Small-Cell Lung Cancer
14. Cetuximab and First-Line Taxane/Carboplatin Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Results of the Randomized Multicenter Phase III Trial BMS099
15. Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
16. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Depression
17. Toward Noninvasive Genomic Screening of Lung Cancer Patients
18. Interpreting Trial Results in Light of Conflicting Evidence: A Bayesian Analysis of Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer
19. Circulating 25-Hydroxyvitamin D, VDR Polymorphisms, and Survival in Advanced Non–Small-Cell Lung Cancer
20. First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic EGFR Mutations
21. VEGF Polymorphisms and Survival in Early-Stage Non–Small-Cell Lung Cancer
22. Phase II Study: Integrated Palliative Care in Newly Diagnosed Advanced Non–Small-Cell Lung Cancer Patients
23. MDM2 Polymorphism, Survival, and Histology in Early-Stage Non–Small-Cell Lung Cancer
24. Phase II Clinical Trial of Chemotherapy-Naïve Patients ≥ 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer
25. Circulating 25-Hydroxyvitamin D Levels Predict Survival in Early-Stage Non–Small-Cell Lung Cancer Patients
26. Molecular Predictors of Response to Epidermal Growth Factor Receptor Antagonists in Non–Small-Cell Lung Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.